European healthtech group Doctolib has entered the UK market through the acquisition of London-based startup Medicus. The company plans to invest over £100 million (~$136 million) in the UK as part of its expansion.
Healthcare systems across Europe are under sustained pressure from ageing populations, chronic disease, staff shortages, and rising patient expectations. Traditional care models are struggling to keep up. At the same time, digital health and AI are advancing rapidly. The core challenge is not a lack of innovation, but overcoming barriers to scaling solutions across fragmented healthcare systems.
Speakers at HBI 2026 discussed how data is “not about simple dashboards”, but is something that can shape investment decisions, sometimes in a way that runs counter to intuition, on a panel entitled 'Building customer growth engines; The power of data and KPIs to drive investment decisions'.
US-based Contract Development and Manufacturing Organisation (CDMO) Alcami Corp, backed by private equity firms GHO Capital, The Vistria Group and Ampersand Capital Partners, is acquiring Netherlands-based contract packaging firm Tjoapack.
Implementation of AI is more advanced in diagnostic imaging than any other part of healthcare. Two imaging providers presented case studies to illustrate how it is being used and providing immense benefits at HBI’s 2026 conference, in a session entitled ‘AI as a value creation lever: Case studies from diagnostics’.
This week, we look at the top 5 for-profit dental groups in the UK by revenue. The data has been sourced from the HBI Intelligence database and respective company reports. The UK’s private dental market has seen significant corporate consolidation over the past decade, with private equity playing a central role in shaping the competitive […]
The UK’s private dental sector is facing a period of significant regulatory and structural change, and it could affect investors and businesses across the industry.
Sun Pharmaceutical, India’s largest drug maker by revenue, has agreed to acquire US-listed Organon, which has a portfolio of therapies and products in women’s health, biosimilars and established medicines, for an enterprise value of $11.7 billion. This marks the largest overseas acquisition by an Indian pharmaceutical company to date.
Pan-European private equity firm Astorg is acquiring American medical device maker Thermo Fisher Scientific’s microbiology business for around $1 billion. Astorg plans to run the business as a standalone platform, focusing on organic growth, selective M&A, and operational improvements.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
